PMC4840897_01
Representative images of intracranial response to TDM1 among four patients treated at the University of North Carolina at Chapel Hill
nihms777375f1.jpg
PMC4840897_03_nihms777375f1.jpg
F1
T-DM1 following WBRT in September 2014. The patient remained stable and progression free with reduction in her 2 brain lesions and no new lesions while on TDM1 for over 12 months (Figure 1, Patient 3).
PMC4840897_02
Representative images of intracranial response to TDM1 among four patients treated at the University of North Carolina at Chapel Hill
nihms777375f1.jpg
PMC4840897_03_nihms777375f1.jpg
F1
T-DM1 following WBRT in September 2014. The patient remained stable and progression free with reduction in her 2 brain lesions and no new lesions while on TDM1 for over 12 months (Figure 1, Patient 3).
PMC4840897_03
Representative images of intracranial response to TDM1 among four patients treated at the University of North Carolina at Chapel Hill
nihms777375f1.jpg
PMC4840897_03_nihms777375f1.jpg
F1
T-DM1 following WBRT in September 2014. The patient remained stable and progression free with reduction in her 2 brain lesions and no new lesions while on TDM1 for over 12 months (Figure 1, Patient 3).
PMC4840897_04